Literature DB >> 8726221

Amino acid concentration in dementia of the Alzheimer type and multi-infarct dementia.

Y Mochizuki1, M Oishi, M Hara, T Takasu.   

Abstract

Amino acids were measured in nine cases of dementia of the Alzheimer type, 10 cases of multi-infarct dementia, and 10 healthy controls. The severity of dementia was examined using mini-mental state test (MMST). Amino acid analysis (41 kinds) in the cerebrospinal fluid (CSF) and serum was performed in the Special Reference Laboratories. In the dementia of the Alzheimer type group, methionine and alanine concentrations in the CSF were significantly increased, and the CSF/serum ratios for both the alanine and glycine concentrations were significantly increased, in comparison with the healthy control group. In the multi-infarct dementia group, glycine, methionine, threonine, phenylalanine, and citrulline concentrations in the CSF were all higher than in the healthy control group. Significant negative correlations were found between the MMST score and the alanine, urea, arginine, and alpha-aminobutyric acid concentrations in the CSF. The number of amino acids which exhibited abnormality in dementia of the Alzheimer type and multi-infarct dementia was greater in the present study than in previous reports.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726221

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  5 in total

1.  Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.

Authors:  Zhiguang Huo; Lei Yu; Jingyun Yang; Yun Zhu; David A Bennett; Jinying Zhao
Journal:  Neurobiol Aging       Date:  2019-11-05       Impact factor: 4.673

2.  1H NMR Analysis of Cerebrospinal Fluid from Alzheimer's Disease Patients: An Example of a Possible Misinterpretation Due to Non-Adjustment of pH.

Authors:  Thomas Cruz; Stéphane Balayssac; Véronique Gilard; Robert Martino; Christian Vincent; Jérémie Pariente; Myriam Malet-Martino
Journal:  Metabolites       Date:  2014-02-19

3.  Serum Amino Acid Profiles in Normal Subjects and in Patients with or at Risk of Alzheimer Dementia.

Authors:  Gaetano Corso; Adriana Cristofano; Nadia Sapere; Giancarlo la Marca; Antonella Angiolillo; Michela Vitale; Roberto Fratangelo; Teresa Lombardi; Carola Porcile; Mariano Intrieri; Alfonso Di Costanzo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2017-05-04

4.  Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes.

Authors:  Mariusz G Fleszar; Jerzy Wiśniewski; Marzena Zboch; Dorota Diakowska; Andrzej Gamian; Małgorzata Krzystek-Korpacka
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

5.  Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid.

Authors:  Nathan Hwangbo; Xinyu Zhang; Daniel Raftery; Haiwei Gu; Shu-Ching Hu; Thomas J Montine; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Dongfang Wang; Qiang Fei; Lisa Bettcher; Cyrus P Zabetian; Elaine R Peskind; Ge Li; Daniel E L Promislow; Marie Y Davis; Alexander Franks
Journal:  Metabolites       Date:  2022-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.